(A) Replacing existing factor "(o)" in clause 6 with the following: "(o) using a drug belonging to the non-steroidal anti-inflammatory class of drugs, excluding aspirin, paracetamol and topical non-steroidal anti-inflammatory drugs, for a continuous period of at least seven days before the clinical onset of ischaemic heart disease, where the last dose of the drug was taken within the seven days before the clinical onset of ischaemic heart disease; or"; and (B) Replacing existing factor "(ee)" in clause 6 with the following: "(ee) using a drug belonging to the non-steroidal anti-inflammatory class of drugs, excluding aspirin, paracetamol and topical non-steroidal anti-inflammatory drugs, for a continuous period of at least seven days before the clinical worsening of ischaemic heart disease, where the last dose of the drug was taken within the seven days before the clinical worsening of ischaemic heart disease; or".

3. The amendment made by this instrument applies to all matters to which Instrument No. 90 of 2007, as amended by Instrument No. 44 of 2009 and Instrument No. 97 of 2010, section 120B of the Veterans’ Entitlements Act 1986 and section 339 of the Military Rehabilitation and Compensation Act 2004 apply.

4. The amendment made by this instrument takes effect from 2 November 2011.

Dated this twenty-first day of October 2011

The Common Seal of the ) Repatriation Medical Authority ) was affixed to this instrument ) in the presence of: )

Made in Toronto, Canada

Address

Terms of Use

Read the Terms of Use Agreement to see the terms that apply to your use of our products (including this website).
Our service is entirely run by computer algorithms. Translations are not human-vetted. There may be inaccuracies in information due to our algorithmic extraction of information. Always consult the official source when making use of legal information.